Replies to post #2796 on Iovance Biotherapeutics Inc (IOVA)

[dstock07734]

What's ORR? Is it 26%? The treatment costs over half a million dollars and patients have to go through intensive chemo to temporarily wipe out lymphocytes, and receive the treatment. In the end, the ORR is only 26%. The future of this company is dire.